Assenagon Asset Management S.A. Sells 132,516 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO)

Assenagon Asset Management S.A. cut its holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) by 65.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 69,799 shares of the medical instruments supplier’s stock after selling 132,516 shares during the period. Assenagon Asset Management S.A.’s holdings in Harvard Bioscience were worth $147,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of HBIO. GSA Capital Partners LLP purchased a new stake in Harvard Bioscience in the third quarter worth $30,000. SG Americas Securities LLC bought a new position in shares of Harvard Bioscience during the 3rd quarter worth $36,000. Avior Wealth Management LLC increased its holdings in Harvard Bioscience by 1,118.1% in the 3rd quarter. Avior Wealth Management LLC now owns 14,569 shares of the medical instruments supplier’s stock worth $39,000 after acquiring an additional 13,373 shares during the last quarter. Cubist Systematic Strategies LLC bought a new stake in Harvard Bioscience in the 2nd quarter valued at about $40,000. Finally, Landscape Capital Management L.L.C. bought a new stake in Harvard Bioscience in the 3rd quarter valued at about $50,000. 80.87% of the stock is owned by hedge funds and other institutional investors.

Harvard Bioscience Price Performance

Shares of NASDAQ HBIO opened at $1.74 on Friday. The stock has a fifty day moving average of $2.11 and a 200-day moving average of $2.53. The stock has a market cap of $75.90 million, a PE ratio of -5.27 and a beta of 1.27. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.91 and a current ratio of 2.06. Harvard Bioscience, Inc. has a fifty-two week low of $1.73 and a fifty-two week high of $4.93.

Harvard Bioscience Profile

Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.